Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-744

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 20 mg (71610 0744 15)

Bottle Label 20 mg (71610 0744 15)
Atorvastatin Calcium USP 20 mg film-coated tablets label showing a blister pack for 15 tablets. The label includes storage instructions, manufacturer SciGen Pharmaceuticals Inc. and packager Aphena Pharma, Cookeville, TN. The NDC is 71610-0744-15, with batch and expiration details space provided.*
FDA Label Image

Bottle Label 40 mg (71610 0745 15)

Bottle Label 40 mg (71610 0745 15)
Atorvastatin Calcium USP 40 mg film-coated tablets in a package containing 15 tablets. The label includes storage instructions to keep the product between 20-25 degrees Celsius and out of reach of children. The manufacturer is Sciegen Pharmaceuticals Inc., Hauppauge, NY, and the labeler is Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN 38506. The National Drug Code (NDC) is 71610-0745-15.*
FDA Label Image

Bottle Label 80 mg (71610 0746 15)

Bottle Label 80 mg (71610 0746 15)
Atorvastatin Calcium USP 80 mg film-coated tablets bottle label. The label indicates a quantity of 15 tablets with storage instructions and the NDC number 71610-0746-15. The manufacturer is ScieGen Pharmaceuticals Inc., Hauppauge, NY, and the repackager is Aphena Pharma, Cookeville, TN. The label also notes the product is for prescription use only.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of atorvastatin calcium, indicating its molecular composition including calcium ions and water molecules.*
FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A cumulative incidence graph showing two curves comparing Atorvastatin and placebo groups over a period of up to 3.5 years. The y-axis represents cumulative incidence percentage, while the x-axis represents time in years. The chart includes a hazard ratio (HR) with confidence intervals and p-value for statistical significance.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. Atorvastatin shows a consistently lower cumulative hazard than placebo, with a hazard ratio of 0.63 and a p-value of 0.001.*
FDA Label Image

Figure-03 (Figure 3)

Figure-03 (Figure 3)
A Kaplan-Meier curve showing the percentage of subjects experiencing a cardiovascular event over 5 years for Atorvastatin 10 mg and 80 mg dosages. The graph compares time to first major cardiovascular event with two lines, indicating a hazard ratio of 0.78 and statistically significant difference (P=0.0002).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.